Abstract
Purpose
The Metastatic spinal cord compression (MSCC) secondary to lung cancer (LC) has worse prognosis when compared to MSCC related to other solid tumors. The purpose of this study is to identify the survival time and the prognostic factors in the MSCC secondary to LC.
Methods
A systematic review of the literature has been carried out. Studies published between January 2005 and March 2015 were identified through the electronic database PubMed and LILACS. Two independent reviewers selected the articles.
Results
7 studies were identified, which met the inclusion criteria, involving 1010 patients. The survival in 6 and 12 months ranged between 18 and 61 %, and between 3.8 and 32 %, respectively. The median survival ranged between 2.8 and 9 months. The variables related to the survival improvement were: female, performance status 1 or 2, pre-radiotherapy and postoperative ambulatory status, absence of bone metastases and visceral metastases, interval from cancer diagnosis to spinal metastases or radiotherapy of MSCC >15 months, slower (>7 days) development of motor deficit, and the neurological status at the postoperative.
Conclusions
The prognosis of the MSCC secondary to LC was poor. Considering the small number of studies identified, further research is needed to identify prognostic factors that are independent of the MSCC secondary to LC.
Similar content being viewed by others
References
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics. CA Cancer J Clin 65(2):87–108
Brasil. Instituto Nacional de Câncer (2014) Estimativa 2014: Incidência de Câncer no Brasil. http://www.inca.gov.br/. Accessed 10 Dec 2013
Tsuya A, Kurata T, Tamura K, Fukuoka M (2007) Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer 57(2):229–232
Sun JM, Ahn JS, Lee S, Kim JA, Lee J, Park YH, Park HC, Ahn MJ, Ahn YC (2011) Park K (2011) Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases. Lung Cancer 71(1):89–93
Spinazzé C, Caraceni A, Schrijvers D (2005) Epidural spinal cord compression. Crit Rev Oncol/Hematol 56(3):397–406
Rades D, Abrahm JL (2010) The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 7:590–598
Tabouret E, Cauvin C, Fuentes S, Esterni B, Adetchessi T, Salem N, Madroszyk A, Gonçalves A, Casalonga F, Gravis G (2015) Reassessment of scoring systems and prognostic factors for metastatic spinal cord compression. Spine J 15(5):944–950
Rades D, Douglas S, Veninga T, Schild SE (2012) A validated survival score for patients with metastatic spinal cord compression from non-small cell lung cancer. BMC Cancer 12:302
Rades D, Douglas S, Veninga T, Bajrovic A, Stalpers LJA, Hoskin PJ, Rudat V, Schild SE (2012) Metastatic spinal cord compression in non-small cell lung cancer patients. Strahlenther Onkol 6:472–477
Chen YJ, Chang GC, Chen HT, Yang TY, Kuo BI, Hsu HC, Yang HW, Lee TS (2007) Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine 32(15):413–418
Tancioni F, Navarria P, Pessina F, Attuati L, Mancosu P, Alloisio M, Scorsetti M, Santoro A, Baena RRY (2012) Assessment of prognostic factors in patients with metastaic epidural spinal Cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience. Eur Spine J 21(1):146–148
Ogihara S, Seichi A, Hozumi T, Oka H, Leki R, Nakamura K, Kondoh T (2006) Prognostic factors for patients with spinal metastases from lung cancer. Spine 31(14):1585–1990
Chaichana KL, Pendleton C, Sciubba DM, Wolinsky JP, Gokaslan ZL (2009) Outcome following decompressive surgery for different histological types of metastatic tumors causing epidural spinal cord compression. J Neurosurg Spine 11:56–63
Silva GT, Bergmann A, Thuler LC (2015) Incidence, associated factors and survival in metastatic spinal cord compression secondary to lung cancer. Spine J 15(6):1263–1269
Morgen SS, Lund-Andersen C, Larsen CF, Engelholm SA, Dahl B (2013) Prognosis in patients with symptomatic metastatic spinal cord compression. Spine 38(16):1362–1367
Mak KS, Lee LK, Mak RH, Wang S, Pile-Spellman J, Abrahm JL, Prigerson HG, Balboni TA (2011) Incidence and treatment patterns in hospitalizations for malignant spinal cord compression in the United States, 1998–1996. Int J Radiat Oncol Biol Phys 80:824–831
Lopez-Olivo MA, Shah NA, Pratt G, Risser JM, Symanski E, Suarez-Almazor ME (2012) Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 20(11):2985–2998
Bach F, Agerlin N, Sorensen JB, Rasmussen TB, Dombernowsky P, Sorensen OS, Hansen HH (1992) Metastatic spinal cord compression secondary to lung cancer. J Clin Oncol 10(11):1781–1787
Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, Rudat V, Schild SE (2011) Final results of a prospective study comparing the local control of short-course and long-course radiotherapy for metastatic spinal cord compression. Int J Radiat Oncol Biol Phys 79:524–530
Conway R, Graham J, Kidd J, Levack P (2007) What happens to people after malignant cord compression¿ Survival, function, quality of life, emotional well-being and place of care 1 month after diagnosis. Clin Oncol 19:56–62
Weigel B, Maghsudi M, Neumann C (1999) Surgical management of symptomatic spinal metastases: postoperative outcome and quality of life. Spine 24:2240–2246
Rades D, Weber A, Karstens JH, Schild SE, Bartscht T (2014) Prognostic role of the number of involved extraspinal organs in patients with metastatic spinal cord compression. Clin Neurol Neurosurg 118C:12–15
Quraishi NA, Manoharan SR, Arealis G, Khurana A, Elsayed S, Edwards KL, Boszczyk BM (2013) Accuracy of the revised Tokuhashi score in predicting survival in patients with metastatic spinal cord compression (MSCC). Eur Spine J 22(Suppl 1):S21–S26
Zhang D, Yin H, Wu Z, Yang X, Liu T, Xiao J (2013) Surgery and survival outcomes of 22 patients with epidural spinal cord compression caused by thyroid tumor spinal metastases. Eur Spine J 22(3):569–576
Quraishi NA, Rajagopal TS, Manoharan SR, Elsayed S, Edwards KL, Boszczyk BM (2013) Effect of timing of surgery on neurological outcome and survival in metastatic spinal cord compression. Eur Spine J 22(6):1383–1388
Helweg-Larsen S, Sørensen PS, Kreiner S (2000) Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables influencing survival and gait function in 153 patients. Int J Radiat Oncol Biol Phys 46:1163–1169
Hoskin PJ, Grover A, Bhana R (2003) Metastatic spinal cord compression: radiotherapy outcome and dose fractionation. Radiother Oncol 68:175–180
Tokuhashi Y, Uei H, Oshima M, Ajiro Y (2014) Scoring system for prediction of metastatic spine tumor prognosis. World J Orthop 5(3):262–271
Leithner A, Radl R, Gruber G, Hochegger M, Leithner K, Welkerling H, Rehak P, Windhager R (2008) Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 17(11):1488–1495
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
We certify that there is no actual or potential conflict of interest in relation to this article.
Rights and permissions
About this article
Cite this article
da Silva, G.T., Bergmann, A. & Thuler, L.C.S. Prognostic factors in patients with metastatic spinal cord compression secondary to lung cancer: a systematic review of the literature. Eur Spine J 24, 2107–2113 (2015). https://doi.org/10.1007/s00586-015-4157-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-015-4157-x